|
| | SPT patients (n = 77) | Patients screened before NSPT (n = 21) | Patients screened after NSPT (n = 14) | Total treated patients (n = 91) |
|
| Diabetes (diabetes, prediabetes, healthy) | 0, 22, 55 | 1, 8, 12 | 0, 4, 10 | 0, 26, 65 |
| HbA1c (%) | 5.41 ± 0.33 (4.7–6.4) | 5.62 ± 0.64 (4.8–7.6) | 5.48 ± 0.41 (5.0–6.1)
∆ = 0,03 ± 0,22 | 5.42 ± 0.34 (4.7–6.4) |
| HbA1c (mmol) | 35.69 ± 3.51 (28–47) | 37.95 ± 7.14 (29–60) | 36.50 ± 4.75 (31–44)
∆ = 0.36 ± 2.34 | 35.81 ± 3.71 (28–47) |
| Number of pockets between 5 and 7 mm | 6.19 ± 6.79 (0–36) | 23.62 ± 22.09 (1–93) | 6.15 ± 8.63 (1–33)
∆ = 14.64 ± 15.50 (-60– 0) | 6.18 ± 6.99 (0–36) |
| Number of pockets >7 mm | 1.16 ± 2.08 (0–12) | 7.33 ± 7.41 (0–34) | 1.57 ± 2.21 (0–6)
∆ = -2,07 ± 3,15 (-11 – 0) | 1.22 ± 2.09 (0–12) |
| Number of pockets >5 mm | 7.35 ± 8.07 (0–39) | 30.95 ± 27.17 (7–104) | 7.29 ± 8.41 (1–33)
∆ = -22.36 ± 19,90 (-71 −1) | 7.40 ± 8.05 (0–39) |
| Number of missing teeth | 3.91 ± 4.48 (0–22) | 3.57 ± 3.35 (0–12) | 3.07 ± 2.92 (0–9)
∆ = 0,21 ± 0,43 (0–1) | 3.81 ± 4,30 (0–22) |
| Number of implants | 1.31 ± 2.55 (0–12) | 0.57 ± 1.16 (0–4) | 0.93 ± 1.54 | 1.25 ± 2.42 (0–12) |
| FMBS% | 14.90 ± 13.34 (0–53) | 59.33 ± 31.95 (7–100) | 17.77 ± 14.31 (2–50)
∆ = -32,43 ± 26,60 (-81 –0) | 15.31 ± 13.44 (0–53) |
| FMPS% | 26.19 ± 13.98 (0–65) | 64.10 ± 27.34 (10–100) | 25.31 ± 7.09 (16–45)
∆ = -33.57 ± 29.39 (-77 – +12) | 26.07 ± 13.18 (0–65) |
| Risk group | Low: 6
Slightly elevated: 0
Moderate: 24
High: 31
Very high: 16 | Low: 5
Slightly elevated: 1
Moderate: 3
High: 9
Very high: 3 | — | Low: 10
Slightly elevated: 1
Moderate: 26
High: 36
Very high: 18 |
| Total risk score | 9.70 ± 5.11 (0–24) | 9.00 ± 4.66 (0–20) | — | 9.55 ± 4.97 (0–24) |
| Periodontitis stage | Stage I: 0
Stage II: 3
Stage III: 53
Stage IV: 21 | Stage I: 0
Stage II: 0
Stage III: 15
Stage IV: 6 | — | Stage I: 0
Stage II: 3
Stage III: 64
Stage IV: 24 |
| Periodontitis grade | A: 0
B: 22
C: 55 | A: 0
B: 3
C: 18 | — | A: 0
B: 24
C: 67 |
|
